American journal of hematology 2021 Sep 17
Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high-risk multiple myeloma.
Related Questions
This is rare but I've seen it twice last year! One with melanoma on nivolumab and one with lung cancer on pembrolizumab (both cases in deep remission)...
New comment by Medical Oncologist at Winship Cancer Institute of Emory University ( April 8, 2025)
Comprehensive, clear, and actionable. Thanks!